Portal de Murcia

www.portaldemurcia.com

• Home
• Business
• Hotels
• Restaurants
• News
• Advertisement

Joaquin Jordan, Professor of Neuropharmacology at the University of Castilla La Mancha, was one of the speakers who participated in the III biomedical conferences on the latest advances in pulmonology being held today in the UCAM

"The population is not to reject the allergy shots, which reject some components are in this case what you need to do is avoid those components that should manage the best," said Joaquin Jordan, professor at the University Castilla La Mancha in biomedical III conference on the latest developments in pulmonology which have been held at the Catholic University of Murcia.

During the day, part of the cycle of conferences and scientific seminars promoting the Research of the UCAM, degrees in medicine and nursing, will bring together various professionals in the biomedical sector to share experiences and proposals for work and deepen the molecular mechanism , genetic and cellular diseases and problems related to human health.

Estrella Nunez, rector of research at the UCAM, at the opening of the conference, stressed "the great day that lives the university community by the scientific breakthrough, published in the journal Nature on generating animal tissues and organs from cells pluripotent and get human organs. "

How it can affect generic treatment changes and the evolution of asthma, biochemical monitoring, the research in pharmacology or usefulness of tumor markers biochemical lung cancer, have served as a starting point to reflect on the importance of biomedical research in the field of Pneumology in order to show the real situation of medical advances.

Jordan acknowledges that "over the rejection of allergy shots, the data are always positive and there are fewer these rejections".

Similarly, said Isabel Tovar, president of the Academy of Pharmacy of the Region of Murcia, about the usefulness of tumor markers in lung cancer, "We've always wanted to approach the biological reality of this devastating disease, help in the diagnosis and its evolution, and we are on the right track. "

Another important issue to be discussed in the afternoon session will be the treatment of smoking in smokers who are unobstructed airway chronically (COPD) with Chief Smoking specialized in the Community of Madrid, Carlos Jimenez Unit.

Source: UCAM